Clinical trials
Active, not recruiting Phase 2 Lymphoma, B-Cell, Marginal Zone trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| International Extranodal Lymphoma Study Group (IELSG) | 3 |
| Christian Buske | 2 |
| AbbVie | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Celgene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fudan University | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 20 |
| Lymphoma, Mantle-Cell | 6 |
| Lymphoma, Follicular | 5 |
| Waldenstrom Macroglobulinemia | 5 |
| Neoplasms | 4 |
| Recurrence | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, B-Cell | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Non-Hodgkin | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.